PanelComposer: a web-based panel construction tool for multivariate analysis of disease biomarker candidates.

Measuring and evaluating diagnostic efficiency is important in biomarker discovery and validation. The receiver operating characteristic (ROC) curve is a graphical plot for assessing the performance of a classifier or predictor that can be used to test the sensitivity and specificity of diagnostic biomarkers. In this study, we describe PanelComposer, a Web-based software tool that uses statistical results from proteomic expression data and validates biomarker candidates based on ROC curves and the area under the ROC curve (AUC) values using a logistic regression model and provides an ordered list that includes ROC graphs and AUC values for proteins (individually or in combination). This tool allows users to easily compare and assess the effectiveness and diagnostic efficiency of single or multiprotein biomarker candidates. PanelComposer is available publicly at http://panelcomposer.proteomix.org/ and is compatible with major Web browsers.

[1]  S. Hanash,et al.  Mining the plasma proteome for cancer biomarkers , 2008, Nature.

[2]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[3]  Gil Mor,et al.  Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.

[4]  J. Griffiths,et al.  A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS) , 2009, Nature Protocols.

[5]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[6]  Klaus Jung,et al.  Comparison of eight computer programs for receiver-operating characteristic analysis. , 2003, Clinical chemistry.

[7]  Joshua Labaer,et al.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. , 2011, Journal of proteome research.

[8]  Min-Seok Kwon,et al.  Overview and introduction to clinical proteomics. , 2008, Methods in molecular biology.

[9]  Zhao-You Tang,et al.  Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.

[10]  A. Smilde,et al.  Statistical data processing in clinical proteomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  K. Schwamborn,et al.  Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers , 2010, Expert review of proteomics.

[12]  Shelly C. Lu,et al.  Oxidation of specific methionine and tryptophan residues of apolipoprotein A‐I in hepatocarcinogenesis , 2005, Proteomics.

[13]  Sung Won Cho,et al.  Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma , 2009, Proteomics.

[14]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[15]  Oguzhan Alagoz,et al.  Informatics in radiology: comparison of logistic regression and artificial neural network models in breast cancer risk estimation. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[16]  András Kocsor,et al.  ROC analysis: applications to the classification of biological sequences and 3D structures , 2008, Briefings Bioinform..

[17]  Steven J. M. Jones,et al.  Molecular Phenotyping of Thyroid Tumors Identifies a Marker Panel for Differentiated Thyroid Cancer Diagnosis , 2008, Annals of Surgical Oncology.

[18]  Gerard Tromp,et al.  Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. , 2006, Cancer research.

[19]  K. Ha,et al.  Normalization using a tagged-internal standard assay for analysis of antibody arrays and the evaluation of serological biomarkers for liver disease. , 2012, Analytica chimica acta.

[20]  Mary Ann Comunale,et al.  Novel Fucosylated Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2009, Cancer Epidemiology Biomarkers & Prevention.

[21]  R. Dwek,et al.  A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma , 2003, Proteomics.

[22]  Francisco Melo,et al.  StAR: a simple tool for the statistical comparison of ROC curves , 2008, BMC Bioinformatics.

[23]  Viv Bewick,et al.  Statistics review 14: Logistic regression , 2005, Critical care.

[24]  Sanjib Basu,et al.  Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.

[25]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.

[26]  Heather N Watson,et al.  Open Access Research Article Identification of an Autoantibody Panel to Separate Lung Cancer from Smokers and Nonsmokers , 2022 .

[27]  Hailing Lu,et al.  Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. , 2008, Journal of proteome research.

[28]  Martin Möckel,et al.  Logistic regression and CART in the analysis of multimarker studies. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[29]  E K Shultz,et al.  Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example. , 1995, Clinical chemistry.